Korea Pharmaceutical Bio Association will participate in BIO USA 2025 from the 16th...Support for global technology transactions and networking of domestic companies
Jun 10, 2025
|
Bio USA is the largest exhibition in the field of life science, where major pharmaceutical bio companies and research institutes around the world seek new drug pipelines, technology transfer, and joint research cooperation opportunities. About 310 domestic companies will participate this year, the second largest after the United States.
During Bio USA, the association will operate a 'joint public relations center' with nine domestic related organizations, including the Korea Health Industry Promotion Agency, and inform the world of the excellent technology of domestic pharmaceutical bio companies. Along with this, IR events of promising companies will also be held.
In addition, on the 18th (local time), 'Korea Night Receipt' will be held to conduct open innovation through exchanges between domestic and foreign pharmaceutical bio-industry officials. Currently, more than 700 people, including overseas Big Pharma officials, have completed pre-registration, and on-site registration is also possible.
During his stay in Boston, Chairman Noh Yeon-hong will attend the 「K-BioX Boston Summit" and deliver a keynote speech on the theme of 「The Way the Korean Pharmaceutical Bio Industry Should Go」. In addition, practical cooperation plans will be sought through meetings with companies living in Boston's CIC (Cambridge Innovation Center), executives from the New England Life Sciences Association (NEBS), and meetings with companies participating in Bio USA and local companies.
Before participating in Bio USA, Chairman Roh will attend the 『KASBP Symposium』 held in Washington, D.C. and give a keynote speech on the theme 『Chances and Challenges of the Korean Pharmaceutical Bio Industry』. In addition, it plans to seek ways to expand exchanges between life scientists between South Korea and the U.S. through visits to Maryland Life Science Cluster, local companies, and meetings with executives of the Korean American Association of Life Scientists (KAPAL).
This article was translated by Naver AI translator.
